Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
150 participants
INTERVENTIONAL
2001-04-30
2005-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Video-based Intervention Study to Prevent HIV/Sexually Transmitted Diseases (STDs) Among STD Clinic Patients
NCT00137670
Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
NCT00947947
Optimizing Strategies to Improve STD Partner Services
NCT00207454
Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services
NCT01938053
Project RESPECT: The Efficacy of HIV/STD Prevention Counseling
NCT00362791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anglo, Hispanic, or Black AND
* STD diagnosis positive
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew Hogben, PhD
Role: PRINCIPAL_INVESTIGATOR
Centers for Disease Control and Prevention
Christy Sherman, PhD
Role: PRINCIPAL_INVESTIGATOR
Oregon Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Research Institute
Eugene, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R30/CCR 019151
Identifier Type: -
Identifier Source: secondary_id
CDC-NCHSTP-3590
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.